Related Articles
Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature
HER3 protein expression as a risk factor for post‑operative recurrence in patients with early‑stage adenocarcinoma and adenosquamous carcinoma of the cervix
Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow‑up
Response of adenocarcinoma of the uterine cervix to chemoradiotherapy
Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer